Zhang Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$459K Buy
3,636
+38
+1% +$5.01K 0.01% 272
2026
Q1
$501K Buy
3,598
+1,934
+116% +$271K 0.02% 247
2025
Q4
$204K Buy
+1,664
New +$202K 0.01% 330
2025
Q3
Sell
-1,944
Closed -$216K 320
2025
Q2
$216K Sell
1,944
-1,965
-50% -$209K 0.01% 278
2025
Q1
$438K Buy
3,909
+1,503
+62% +$155K 0.02% 213
2024
Q4
$222K Sell
2,406
-66
-3% -$5.94K 0.01% 271
2024
Q3
$207K Sell
2,472
-9,163
-79% -$699K 0.01% 270
2024
Q2
$798K Sell
11,635
-3,576
-24% -$239K 0.06% 155
2024
Q1
$1.11M Buy
15,211
+1,807
+13% +$139K 0.08% 134
2023
Q4
$1.09M Buy
13,404
+3,904
+41% +$304K 0.09% 121
2023
Q3
$712K Sell
9,500
-5,268
-36% -$405K 0.07% 136
2023
Q2
$1.13M Buy
14,768
+6,061
+70% +$483K 0.12% 103
2023
Q1
$722K Buy
8,707
+2,995
+52% +$248K 0.08% 133
2022
Q4
$490K Buy
5,712
+84
+1% +$6.65K 0.06% 148
2022
Q3
$347K Buy
5,628
+142
+3% +$8.95K 0.05% 162
2022
Q2
$339K Buy
5,486
+1,947
+55% +$121K 0.05% 167
2022
Q1
$210K Buy
+3,539
New +$226K 0.04% 207

Other funds holding GILD

Zhang Financial's GILD Position: Q2 2026 in Review

Zhang Financial increased its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, buying an estimated $5.01K and bringing the position to 3,636 shares worth $459K. The position accounts for 0.01% of the portfolio, ranked #272.

Zhang Financial first reported a position in GILD in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.13M in Q2 2023. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Zhang Financial held 3,636 shares of Gilead Sciences worth $459K as of Q2 2026.
  • Zhang Financial bought 38 Gilead Sciences shares in Q2 2026, an estimated $5.01K.
  • Gilead Sciences made up 0.01% of Zhang Financial's portfolio in Q2 2026, its #272 holding.
  • Zhang Financial first reported a position in Gilead Sciences in Q1 2022 and has held it in 17 quarters since.
  • Zhang Financial's Gilead Sciences position peaked at $1.13M in Q2 2023.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Zhang Financial's 13F filing for Q2 2026, filed 30 Jul 2026.